Advertising

TSE:EXE

7.20
0.05 (0.70%) 1d
0
Showing 1 to 15 of 229 entries
DON'T BUY
There's always something that stops him from entering the seniors space in REITs: labour, regulator issues, though again demographics are a positive. That isn't a good enough, though. How will governments with huge debts supplement the entire seniors home space? However, EXE is cheap. This space is too volatile.
other services
DON'T BUY

How COVID will effect this industry, retirement homes? He owns Sienna instead. EXE is much more involved in government-funded LTCs. Along with Chartwell, these two companies are under government scrutiny, so they likely do a much better job than private LTCs. Good question how COVID will affect these homes: there may be increased costs to manage the LTCs, and he expects the government to do more oversight, particularly the incompetent LTCs. He prefers Sienna to EXE, because Sienna is a mix of LTCs and retirement homes, while Chartwell is mostly retirement homes, which has more upside but more competitive. Don't buy purely LTCs, like EXE.

other services
COMMENT

Extendicare has a better chart than Chartwell. It has a head-and-shoulder chart movement. If you take into account the general market sell-off, investors need to be forgiving.

other services
WATCH
He likes the aging demographics. It has been clawing itself back after problems in the US and high level debt. They are focused on their home care and supply chain businesses. They are trying to now go capital light. He is starting to look at it. It is trading at a discount, relative to peers.
other services
BUY
The long-term care homes are all similar. Slow growers, good dividend yielders. Payouts are reasonable. Steady stream of income. Hasn't increased dividend for 3 years. Resistant to recessions. Labour and other costs are going up. Yield around 5%.
other services
HOLD
A great demographic pick. He bought in at $7.01 in 2014 and bought in again at $6.62. He liked how they paid down debt and reduced operations in the US. He likes the dividend and thinks there is still good upside -- maybe another 50%. They have been growing organically and by takeover. He would like to see them pay down more debt. Yield 5%
other services
BUY on WEAKNESS
Enjoys a regulated revenue stream like other retirement homes, so it's fairly safe--but has only 2-5% growth. A long-term hold. Buy at $8, though you can sell it at $10.
other services
DON'T BUY
Long term care. They have about 5% dividend but it is over 100% of cash flow. Sales are growing at 1.2%. The free cash flow yield is not there.
other services
DON'T BUY
Would avoid right now, with government regulation risk, and bad press. There's enough risk for negative press in healthcare stock.
other services
BUY on WEAKNESS
Look at defensive stocks this time of year. EXE's moving averages are moving up. Add more at $8.60. It's overbought now, so expect consolidation first.
other services
HOLD
He bought more in December. They do have some debt -- a little higher than he likes. The payout ratio is such that the dividend is stable, but won't grow. The demographics are in their favour within senior housing. He is happy to keep holding it. Yield 5.7%
other services
BUY
The activist investor? The activist investor owns 9%. It's a leader in Canada. A great demographic play. Good dividend. This could hit $12-14. He's pleased that EXE has come to an agreement with the activist.
other services
DON'T BUY
This sector is almost as bad as airplanes, because there are government regulations and labour issues (minimum wage) and it's labour-intensive. Also. EXE missed their numbers and hasn't done much in two years. They blew their brains out in the U.S. where they got it. Also--his theory--technological advances and government incentives encourage seniors to stay in home and not enter nursing homes. The whole sector falls shorts.
other services
BUY
He bought it years ago. Pays 4-cents each month in dividends. He's doubled-down and averaged down. It doesn't have the normal upside for him, but it's a fine demographic play. People are getting older. He sees 50-100% upside. Safe to buy more here, but he wants them to pay down its debt more.
other services
DON'T BUY
He generally likes the REITs. This one would not be the one he would pick. It is generally more volatile than he would like. The yield is a little bit stretched. SIS-T is one he would prefer slightly.
other services
Showing 1 to 15 of 229 entries

Extendicare Inc(EXE-T) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for Extendicare Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Extendicare Inc(EXE-T) Frequently Asked Questions

What is Extendicare Inc stock symbol?

Extendicare Inc is a Canadian stock, trading under the symbol EXE-T on the Toronto Stock Exchange (EXE-CT). It is usually referred to as TSX:EXE or EXE-T

Is Extendicare Inc a buy or a sell?

In the last year, 1 stock analyst published opinions about EXE-T. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Extendicare Inc.

Is Extendicare Inc a good investment or a top pick?

Extendicare Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Extendicare Inc.

Why is Extendicare Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Extendicare Inc worth watching?

1 stock analyst on Stockchase covered Extendicare Inc In the last year. It is a trending stock that is worth watching.

What is Extendicare Inc stock price?

On 2021-10-19, Extendicare Inc (EXE-T) stock closed at a price of $7.2.